FIELD: chemistry.
SUBSTANCE: invention concerns stable pharmaceutical compositions include azetidine derivatives, particularly N-{1-[bis(4-chlorophenyl)methyl]azetidine-3-yl}-N-(3,5-difluorophenyl)methylsulfonamide, and method of its obtainment. Invention can be applied in medicine.
EFFECT: obtaining new stable pharmaceutical composition based on azetidine derivative.
5 cl, 6 dwg, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SEMIFIRM SYSTEMS CONTAINING DERIVATIVES OF AZETIDINUM | 2004 |
|
RU2343915C2 |
| PHARMACEUTICAL COMPOSITION OF TAXOIDS | 2011 |
|
RU2603833C2 |
| DRUG DOSAGE FORM CONTAINING 6'-FLUORO-(N-METHYL-OR N, N-DIMETHYL-)-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1, 1'-PYRANO[3, 4, b]INDOLE]-4-AMINE | 2011 |
|
RU2589830C2 |
| STABILISED LIPID PREPARATIVE FORM OF APOPTOSIS PROMOTER | 2010 |
|
RU2530642C2 |
| PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2639482C2 |
| CYCLOSPORIN-CONTAINING PHARMACEUTICAL COMPOSITION, METHOD OF SOFT GELATIN CAPSULE PREPARING | 1998 |
|
RU2178293C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING CYCLOSPORINE AS ACTIVE COMPONENT | 2000 |
|
RU2207870C2 |
| PHARMACEUTICAL COMPOSITION, PRODUCT OF TRANSESTERIFICATION OF CORN OIL WITH GLYCEROL AND METHOD OF ITS PREPARING | 1992 |
|
RU2143919C1 |
| PHARMACEUTICAL COMPOUNDS OF CYCLOSPORINE ANALOGUES | 2019 |
|
RU2810897C2 |
| ANTAGONISTS NEUROKININ-1 COMPOSITIONS FOR INTRAVENOUS INTRODUCTION | 2010 |
|
RU2642234C2 |
